HMN 2026: What is the promising therapy to prevent relapses in rare neurological disease
Health Medicine Network,
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising…
Interleukin-6 Receptor Blockade for Relapse-Prevention in MOGAD
Overview of attention for article published in JAMA Neurology, September 2026
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Mentioned by
- news
- 3 news outlets
- blogs
- 2 blogs
- 46 X users
- 1 Facebook page
- bluesky
- 4 Bluesky users
Readers on
- mendeley
- 10 Mendeley